Two studies released this week indicate that health care providers believe that the CA-125 and/or the transvaginal ultrasound are appropriate screening tests for ovarian cancer. There is no medical organization that has endorsed the current tools as appropriate for screening. A large study of almost 80,000 women showed that screening with these two tools did not diagnose ovarian cancer earlier and, in some cases, carried high risks associated with the unnecessary surgeries. The Alliance is encouraged that providers are thinking about ovarian cancer as they see their patients; however, it is concerned by the results of this study, which indicate that providers may be over-testing women for ovarian cancer. Women at high risk of developing ovarian cancer should consult with their doctors about a monitoring protocol or preventive surgery. The Alliance continues to call for better tools to diagnose and treat ovarian cancer.
Ovarian Cancer Screening: Are Doctors Ordering Too Many Tests? (Huffington Post)